Ghrelin mimetics like ipamorelin bind a separate receptor, the ghrelin receptor, and act through a different intracellular pathway
Unfortunately, the current trend is completely the opposite, with a steady increase in overweight and obesity affecting the youngest, putting them at very high risk of developing a veritable epidemic of cardiometabolic diseases in a few years (see our article on this subject)
However, 503A compounding is federally regulated and held to strict quality, sterility, and potency standards
Postgrad Med J 96(1133):156161 Singh K, Aulakh SK, Nijjar GS, Singh S, Sandhu APS, Luthra S, et al (2024) Rebalancing the gut: glucagon-like peptide-1 agonists as a strategy for obesity and metabolic health
GLP-1 aids in decelerating stomach emptying and promoting insulin release while curbing appetite